Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

SALIL GOORHA

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1124241062
CMS profile
232664
Location
MEMPHIS, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$8,533.73

186 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 3 of 4; records 101–150 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

SALIL GOORHA

NPI 1124241062 · CMS profile ID 232664

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

MEMPHIS, TN

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 4; records 101–150 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1124241062?year=2025&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
SALIL GOORHA, NPI 1124241062, CMS profile ID 232664. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1124241062?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). SALIL GOORHA, NPI 1124241062, CMS profile ID 232664. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 4; records 101–150 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1124241062?year=2025&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
SALIL GOORHA, NPI 1124241062, CMS profile ID 232664, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 4; records 101–150 of 186 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1124241062?year=2025&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

186 matching records · $8,533.73 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 186 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–150 of 186.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Legend Biotech USA Inc. $35.0906/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236477566 CMS
SOBI, INC $20.0106/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240232196 CMS
TAIHO ONCOLOGY, INC. $16.7406/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211409820 CMS
Celgene Corporation $27.7606/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184513816 CMS
PFIZER INC. $378.0006/09/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1229647674 CMS
Genmab U.S., Inc. $20.3506/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235926623 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.3505/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223827944 CMS
BeOne Medicines USA, Inc. $24.2405/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202901908 CMS
Janssen Biotech, Inc. $20.2805/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174870641 CMS
PFIZER INC. $3,225.0005/20/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1229634155 CMS
Celgene Corporation $22.6805/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184513798 CMS
Janssen Biotech, Inc. $13.2105/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174870396 CMS
ABBVIE INC. $22.5305/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201947494 CMS
Daiichi Sankyo Inc. $18.3205/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197064057 CMS
Genentech USA, Inc. $18.9605/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211581601 CMS
PFIZER INC. $700.0005/16/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/2026 1229603813 CMS
Daiichi Sankyo Inc. $26.4205/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197063649 CMS
Lilly USA, LLC $19.0405/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186919836 CMS
Genentech USA, Inc. $15.7305/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211581613 CMS
E.R. Squibb & Sons, L.L.C. $14.4805/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184513800 CMS
Kite Pharma, Inc. $21.4905/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212081595 CMS
Adaptive Biotechnologies Corporation $26.0605/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1254939206 CMS
PFIZER INC. $212.1605/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230209456 CMS
GENZYME CORPORATION $22.4205/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233393846 CMS
KYOWA KIRIN, INC. $17.2005/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1222085004 CMS
GlaxoSmithKline, LLC. $26.4805/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191137391 CMS
Syndax Pharmaceuticals, Inc. $19.8205/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238991308 CMS
ABBVIE INC. $19.1904/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201947492 CMS
Daiichi Sankyo Inc. $25.4504/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1197065509 CMS
Legend Biotech USA Inc. $24.1104/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236477564 CMS
Blueprint Medicines Corporation $24.5104/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235812247 CMS
PFIZER INC. $21.6404/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229622656 CMS
SERVIER PHARMACEUTICALS LLC $22.2004/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229110929 CMS
SOBI, INC $14.8804/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240232203 CMS
AstraZeneca Pharmaceuticals LP $13.6104/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206615979 CMS
Geron Corporation $18.5604/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238888890 CMS
Genentech USA, Inc. $16.5204/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211581594 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.6404/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223837644 CMS
Lilly USA, LLC $21.6304/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1186886925 CMS
Janssen Biotech, Inc. $16.4604/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174874254 CMS
Incyte Corporation $18.9504/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225971172 CMS
Celgene Corporation $24.6304/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184513788 CMS
TAIHO ONCOLOGY, INC. $14.4404/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211409822 CMS
BeOne Medicines USA, Inc. $21.7304/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202901906 CMS
Celgene Corporation $25.5104/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184513770 CMS
Celgene Corporation $22.6604/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184513786 CMS
Janssen Biotech, Inc. $10.5503/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174869332 CMS
Takeda Pharmaceuticals U.S.A., Inc. $24.5303/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223892818 CMS
Kite Pharma, Inc. $13.7303/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212081591 CMS
SOBI, INC $18.3503/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240232209 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $14,654.29 79
PY2020 $2,331.93 54
PY2021 $7,744.83 47
PY2022 $6,094.60 146
PY2023 $6,386.00 174
PY2024 $4,852.17 172
PY2025 $8,533.73 186

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $40,805.00 14
PY2024 Principal investigator $163,082.58 31
PY2023 Principal investigator $65,475.00 17
PY2022 Principal investigator $35,015.00 6
PY2021 Principal investigator $34,715.56 24
PY2020 Principal investigator $13,970.03 2
PY2019 Principal investigator $29,494.54 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

14 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Janssen Research & Development, LLC $454.00 10/02/2025 Non-covered Recipient Entity
BAPTIST CLINICAL RESEARCH INSTITUTE
A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC (Tec-Dara) versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants with Relapsed or Refractory Multiple Myeloma MajesTEC-3 No dispute reported 06/30/2026 1175369798
Principal investigator 1 Servier BioInnovation $500.00 06/30/2025 Non-covered Recipient Entity
Baptist Clinical Research Institute, Inc.
CALASPARGASE PEGOL IN ADULTS WITH ALL No dispute reported 06/30/2026 1235967414
Principal investigator 1 Janssen Research & Development, LLC $5,654.00 06/09/2025 Non-covered Recipient Entity
BAPTIST CLINICAL RESEARCH INSTITUTE INC
A Phase 3 Randomized Study Comparing Talquetamab SC in Combination WithDaratumumab SC and Pomalidomide (Tal-DP) or Talquetamab SC in Combination WithDaratumumab SC (Tal-D) Versus Daratumumab SC, Pomalidomide and Dexamethasone(DPd), in Participants With R No dispute reported 06/30/2026 1175369805
Principal investigator 1 Janssen Research & Development, LLC $454.00 05/26/2025 Non-covered Recipient Entity
BAPTIST CLINICAL RESEARCH INSTITUTE INC
A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC (Tec-Dara) versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants with Relapsed or Refractory No dispute reported 06/30/2026 1175369852
Principal investigator 1 ABBVIE INC. $13,083.00 05/07/2025 Non-covered Recipient Entity
BAPTIST CLINICAL RESEARCH
Study Assessing Activity of Intravenous (IV) ABBV-383 Monotherapy Versus Standard Available Therapies in Adult Participants With Relapsed or Refractory Multiple Myeloma No dispute reported 06/30/2026 1202483479
Principal investigator 1 Janssen Research & Development, LLC $5,748.00 04/21/2025 Non-covered Recipient Entity
BAPTIST CLINICAL RESEARCH INSTITUTE INC
A Phase 3 Randomized Study Comparing Talquetamab SC in Combination WithDaratumumab SC and Pomalidomide (Tal-DP) or Talquetamab SC in Combination WithDaratumumab SC (Tal-D) Versus Daratumumab SC, Pomalidomide and Dexamethasone(DPd), in Participants With R No dispute reported 06/30/2026 1175369787
Principal investigator 1 Janssen Research & Development, LLC $958.00 04/17/2025 Non-covered Recipient Entity
BAPTIST CLINICAL RESEARCH INSTITUTE INC
A Phase 3 Randomized Study Comparing Talquetamab SC in Combination WithDaratumumab SC and Pomalidomide (Tal-DP) or Talquetamab SC in Combination WithDaratumumab SC (Tal-D) Versus Daratumumab SC, Pomalidomide and Dexamethasone(DPd), in Participants With R No dispute reported 06/30/2026 1175369843
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $6,000.00 04/11/2025 Non-covered Recipient Entity
Baptist Clinical Research Institute
A Phase 3b randomized study of lenalidomide (CC-5013)plus rituximab maintenance therapy followed by lenalidomide singe-agent maintenance vs. rituximab maintenance in subjects with relapsed/refractory follicular, marginal zone or mantle cell lymphoma No dispute reported 06/30/2026 1235998798
Principal investigator 1 Servier BioInnovation $2,500.00 03/12/2025 Non-covered Recipient Entity
Baptist Clinical Research Institute, Inc.
CALASPARGASE PEGOL IN ADULTS WITH ALL No dispute reported 06/30/2026 1235967399
Principal investigator 1 Servier BioInnovation $1,500.00 03/12/2025 Non-covered Recipient Entity
Baptist Clinical Research Institute, Inc.
CALASPARGASE PEGOL IN ADULTS WITH ALL No dispute reported 06/30/2026 1235967403
Principal investigator 1 Servier BioInnovation $1,500.00 03/12/2025 Non-covered Recipient Entity
Baptist Clinical Research Institute, Inc.
CALASPARGASE PEGOL IN ADULTS WITH ALL No dispute reported 06/30/2026 1235967406
Principal investigator 1 Servier BioInnovation $1,500.00 03/12/2025 Non-covered Recipient Entity
Baptist Clinical Research Institute, Inc.
CALASPARGASE PEGOL IN ADULTS WITH ALL No dispute reported 06/30/2026 1235967410
Principal investigator 1 Janssen Research & Development, LLC $454.00 02/03/2025 Non-covered Recipient Entity
BAPTIST CLINICAL RESEARCH INSTITUTE INC
A Phase 3 Randomized Study Comparing Teclistamab in Combination with Daratumumab SC (Tec-Dara) versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants with Relapsed or Refractory No dispute reported 06/30/2026 1175369835
Principal investigator 1 Servier BioInnovation $500.00 01/15/2025 Non-covered Recipient Entity
Baptist Clinical Research Institute, Inc.
CALASPARGASE PEGOL IN ADULTS WITH ALL No dispute reported 06/30/2026 1235967397